Antidiabetic treatment improves prognosis after radical resection in hepatocellular carcinoma patients with diabetes mellitus: a retrospective cohort study from 2000 to 2013.

导出 OA

翻译打印收藏纠错

第一作者： Jing-Zhu,Cao

第一单位： Department of Endocrinology, Changhai Hospital, Naval Medical University, Shanghai, China.

作者： Jing-Zhu,Cao ^[1] ; Zhen-Guang,Wang ^[2] ; Jian,Yu ^[3] ; Yuan-Ping,Tao ^[2] ; Yuan,Yang ^[3] ; Hui,Liu ^[3] ; Wei-Ping,Zhou ^[2] ; Jin,Lu ^[3] ; Qin,Huang ^[2]

作者单位： Department of Endocrinology, Changhai Hospital, Naval Medical University, Shanghai, China. ^[1] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China. ^[2] National Liver Tissue Bank, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China. ^[3]

关键词 Hepatocellular carcinoma (HCC)antidiabetic treatment diabetes mellitus (DM)insulin metformin

DOI 10.21037/jgo-22-478

PMID 35837203

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交